(Q51575416)

7 April 2018

title

Diet- and valproate-induced transient hyperammonemia: effect of L-carnitine. (English)

1 reference

7 April 2018

author name string

Gidal BE

1

1 reference

7 April 2018

Inglese CM

2

1 reference

7 April 2018

Meyer JF

3

1 reference

7 April 2018

Pitterle ME

4

1 reference

7 April 2018

Antonopolous J

5

1 reference

7 April 2018

Rust RS

6

1 reference

7 April 2018

publication date

1 May 1997

1 reference

7 April 2018

published in

Pediatric Neurology

1 reference

7 April 2018

volume

16

1 reference

7 April 2018

issue

4

1 reference

7 April 2018

page(s)

301-305

1 reference

7 April 2018

Chronic valproic acid therapy and incidence of increases in venous plasma ammonia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

Carnitine deficiency and hyperammonemia associated with valproic acid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

Carnitine deficiency syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

Carnitine: metabolism and clinical chemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

Beta-oxidation of valproic acid. I. Effects of fasting and glucose in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

Hepatic and renal contributions to valproic acid-induced hyperammonemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

Effect of the antiepileptic drug sodium valproate on glutamine and glutamate metabolism in isolated human kidney tubules

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

Inhibition of ureagenesis by valproate in rat hepatocytes. Role of N-acetylglutamate and acetyl-CoA

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

Nutritional influence on serum ammonia in young patients receiving sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

Effect of associated antiepileptic treatment on valproate-induced hyperammonemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

Reversal of valproic acid-associated impairment of carnitine uptake in cultured human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

Effects of valproate and citrulline on ammonium-induced encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

Hyperammonemia with valproic acid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

Acute changes of blood ammonia may predict short-term adverse effects of valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

Valproate induced encephalopathy treated with carnitine in an adult

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900026-X

7 January 2021

10.1016/S0887-8994(97)00026-X

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018